Your session is about to expire
← Back to Search
Steady Intervention for Obesity (STEADY Trial)
STEADY Trial Summary
This trial is investigating a low-burden self-weighing intervention to see if it is feasible and acceptable with the goal of preventing weight gain.
- Overweight and Obesity
STEADY Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.STEADY Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does the criteria for entry into this investigation include applicants aged 35 and above?
"Participants must meet the eligibility criteria in order to partake, which stipulates that they be between 18 and 70 years old."
What is the highest number of participants currently involved in this medical experiment?
"Indeed, the information from clinicaltrials.gov shows that this clinical trial is actively seeking participants. The study was originally posted on April 16th 2021 and has recently been updated September 15th 2022 for a total of 40 possible enrolments at 1 site."
To whom is this experiment available?
"This trial seeks 40 adults ranging in age from 18 to 70 who have experienced recent weight loss. In order to be eligible, participants must also satisfy the following criteria: BMI of 30 or above (or between 25 and 29 with associated comorbidities), weigh no more than 375 lbs., ability to send/receive texts at least once per month, not enrolled in a behavioral weight loss program, opt-out of enrolling in such a program within the next month, weighed themselves less than 5 times per week on average over prior month, not pregnant or planning pregnancy for 6 months after enrolment date; and exclude those undergoing chemotherapy or"
Are there vacancies available for participants in this trial?
"Data from clinicaltrials.gov show that this research project, which was first publicized on April 16th 2021, is currently enrolling volunteers. The study's information has been most recently updated as of September 15th 2022."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger